StonvexLoading…
StonvexStonvexStonvexCore line items from XPOF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $314.88M | $320.35M | $317.94M | $243.20M |
Operating Income | $19.85M | $-53.61M | $34.91M | $13.32M |
Net Income | $-38.68M | $-67.66M | $-4.00M | $1.22M |
EPS (Diluted) | $-1.47 | $-2.27 | $-0.52 | $-0.88 |
Total Assets | $345.63M | $403.40M | $529.53M | $482.69M |
Total Liabilities | $717.59M | $597.40M | $624.41M | $382.68M |
Cash & Equivalents | $45.86M | $32.74M | $37.09M | $37.37M |
Free Cash Flow OCF − CapEx | $24.74M | $6.96M | $25.28M | $43.11M |
Shares Outstanding | 34.80M | 32.00M | 39.70M | 25.30M |